KK

Kamal Kishore

Director Additional Director DIN 08506517
DIN 08506517 First appointment Jul 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamal Kishore

Data last updated:

Kamal Kishore was an Additional Director at Dacso Labs Private Limited (2024) and Director at Bioville Pharma Private Limited (2019–2024). The companies operate in Business Services.

DIN 08506517
Primary Designation Additional Director
Industry Business Services
First Appointment 10 Jul 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dacso Labs Private Limited U46497DL2023PTC413388
Additional Director05 Feb 20242023Strike Off
Bioville Pharma Private Limited U51100DL2019PTC352464
Director10 Jul 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dacso Labs Private Limited
Bioville Pharma Private Limited
Premium access

Shareholding and investment profile for Kamal Kishore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Kishore

Kamal Kishore was first appointed on 10 Jul 2019 as Director at Bioville Pharma Private Limited. The most recent appointment on record is 05 Feb 2024 at Dacso Labs Private Limited.

Kamal Kishore held 2 earlier board appointments: Dacso Labs Private Limited (Additional Director, 05 Feb 2024 to 12 May 2024); Bioville Pharma Private Limited (Director, 10 Jul 2019 to 12 May 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available